These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6384701)

  • 21. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
    Giannetti A; Orecchia G
    Dermatologica; 1983; 167(5):280-2. PubMed ID: 6653853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical squaric acid dibutylester therapy for alopecia areata.
    Flowers FP; Slazinski L; Fenske NA; Pullara TJ
    Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
    [No Abstract]   [Full Text] [Related]  

  • 23. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
    Tan E; Tay YK; Goh CL; Chin Giam Y
    Int J Dermatol; 2002 Nov; 41(11):748-53. PubMed ID: 12452996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
    Stinco G; Patrone P
    Contact Dermatitis; 2000 Jul; 43(1):52-3. PubMed ID: 10902598
    [No Abstract]   [Full Text] [Related]  

  • 25. Thymopentin in the treatment of severe alopecia areata.
    Tosti A; Manuzzi P; Gasponi A
    Dermatologica; 1988; 177(3):170-4. PubMed ID: 3049174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Squaric acid dibutyl ester and diphencyprone in the therapy of alopecia areata].
    Tosti A; Caponeri GM; Primativo R; Melino M; Veronesi S
    G Ital Dermatol Venereol; 1985; 120(5):371-3. PubMed ID: 4077112
    [No Abstract]   [Full Text] [Related]  

  • 27. Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
    Pardasani AG; Turner E; McMichael AJ
    Arch Dermatol; 2001 Jul; 137(7):970-2. PubMed ID: 11453831
    [No Abstract]   [Full Text] [Related]  

  • 28. Squaric acid dibutyl ester in the treatment of alopecia areata.
    Barth JH; Darley CR; Gibson JR
    Dermatologica; 1985; 170(1):40-2. PubMed ID: 3882480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of alopecia areata with diphencyprone].
    Suditu G; Toma A; Voiculescu M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentiginous eruption due to topical immunotherapy.
    Tosti A; Piraccini BM; Misciali C; Vincenzi C
    Arch Dermatol; 2003 Apr; 139(4):544-5. PubMed ID: 12707112
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
    Nasca MR; Micali G; Pulvirenti N; Licastro Cicero R
    Eur J Dermatol; 1998 Mar; 8(2):125-6. PubMed ID: 9649675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alopecia areata and treatment with the diethylester of squaric acid. Behavior of lymphocyte subpopulations].
    Pigatto PD; Gini R; Altomare GF
    G Ital Dermatol Venereol; 1985; 120(3):227-30. PubMed ID: 4030021
    [No Abstract]   [Full Text] [Related]  

  • 33. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
    Pigatto PD; Rapisarda R; Polenghi MM; Altomare GF
    G Ital Dermatol Venereol; 1987 Dec; 122(12):667-70. PubMed ID: 3329149
    [No Abstract]   [Full Text] [Related]  

  • 34. Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.
    Chen CA; Carlberg V; Kroshinsky D
    Pediatr Dermatol; 2017 Jan; 34(1):e44-e46. PubMed ID: 27699860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the sildenafil effect on alopecia areata in childhood: An open-pilot comparison study.
    Sarifakioglu E; Degim IT; Gorpelioglu C
    J Dermatolog Treat; 2006; 17(4):235-7. PubMed ID: 16971319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of alopecia areata with squaric acid dibutylester.
    Micali G; Cicero RL; Nasca MR; Sapuppo A
    Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squaric acid sensitization is not required for response in the treatment of alopecia areata.
    Vedak P; Kroshinsky D
    J Am Acad Dermatol; 2015 Sep; 73(3):471-6. PubMed ID: 26282797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
    Avitabile S; Sordi D; Garcovich S; Colonna L; De Luca A; Nasorri F; Mazzanti C; Cavani A
    J Dermatol; 2015 Jan; 42(1):98-9. PubMed ID: 25495487
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.